Cane Capital Partners »

Aileron Therapeutics shares owned by Cane Capital Partners

Quarter-by-quarter ownership of Aileron Therapeutics (RNTX) shares owned by Cane Capital Partners from 13F filings

Historical chart of Cane Capital Partners investment in Aileron Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Aileron Therapeutics held by Cane Capital Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Aileron Therapeutics by Cane Capital Partners

Quarter filed Position value Share count Share price at filing
2026-03-31 $23k 18k 1.30

More positions owned by Cane Capital Partners

Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
NVIDIA Corporation (NVDA)
Meta Platforms Com Cl A (META)
Procter & Gamble Company (PG)
Apple (AAPL)
Microsoft Corporation (MSFT)
Exxon Mobil Corporation (XOM)
JPMorgan Chase & Co. (JPM)
Advanced Micro Devices (AMD)
Boeing Company (BA)
Coinbase Global Com Cl A (COIN)
Arthur J. Gallagher & Co. (AJG)
Broadcom (AVGO)
Bank of America Corporation (BAC)

View all positions for Cane Capital Partners

Top funds holding Aileron Therapeutics

Voss Capital
BIOS Capital Management
Vanguard Capital Management
University of Texas Investment Management Company
Cable Car Capital
Prosight Management
Sigma Planning
Geode Capital Management
Texas Capital Bank Wealth Management Services
Sequoia Financial Advisors
Gagnon Securities
Rima Management
Palogic Value Management
Vanguard Fiduciary Trust
Rock Creek Group

View all funds holding Aileron Therapeutics